Skip to main content
webinar register page
Webinar Registration
Facebook
Twitter
LinkedIn
Microsoft (Outlook)
Topic
Shaping of anti-tumor immunity in the tumor microenvironment
Description
Tumors grow in a microenvironment in which malignant cells entertain intricated relations with stromal and immune cells Both T and B cell anti-tumor immunity are generated in Tertiary Lymphoid Structures adjacent to tumor beds. In situ generated immunity impacts patient’s prognosis and response to immunotherapy.
The production of this webinar is supported by Thermo Fisher Scientific.
Thermo Fisher Scientific has had no influence on the content, and full editorial control remains the sole responsibility of IUIS.
Time
Jul 25, 2022 03:00 PM in
Amsterdam, Berlin, Rome, Stockholm, Vienna
*
Required information
Loading
Register
I agree that Thermo Fisher may use this information to contact me about programs, products or services; I may opt-out at any time.
Your personal data will be handled according to Thermo Fisher’s Privacy Policy. In addition, if you are located within a Distributor Territory, you may be contacted directly by them. We never sell your data to anyone. You can unsubscribe anytime by clicking the unsubscribe link in the footer of our emails, or by replying to our emails and asking to be unsubscribed.
Speakers
Wolf H. Fridman
Speaker
Professor Wolf H. Fridman is Professor Emeritus of Immunology at Université Paris Cité, in Paris, France. His research focused on the analysis of the tumor microenvironment. Since 2005, his studies have changed the paradigm of host/cancer interactions by demonstrating that the ‘immune contexture”, taking in account the functionality, the location and the density of the immune infiltrate is the major prognostic factor for human cancers. He has recently demonstrated that Tertiary Lymphoid Structures (TLS), adjacent to tumor beds shape efficient T and B cell immunity, the later resulting in the production of anti-tumor antibodies that impact patient’s prognosis and response to immunotherapy. These findings open the way for novel immune-based tools for efficient prognosis and therapy of cancers.
Rosana Pelayo
Moderator
Rosana Pelayo holds a Principal Investigator position in the Mexican Institute for Social Security, Puebla, Mexico, where she leads the Oncoimmunology Laboratory. Rosana Pelayo is Past-President of the Mexican Society of Immunology and Vice-Chair of the IUIS Education Committee.
Thermo Fisher Scientific
Sponsor
Thermo Fisher Scientific understands your samples are precious in immunology research. Our products and technologies support your wise use of samples to get qualitative and quantitative measurements when evaluating experiments. Our mission is to enable our customers to make the world healthier, cleaner, and safer.
×
Share via Email
All fields are required
Your Information
Send to
Message preview
Hi there, You are invited to a Zoom webinar. When: Jul 25, 2022 03:00 PM Amsterdam, Berlin, Rome, Stockholm, Vienna Topic: Shaping of anti-tumor immunity in the tumor microenvironment Register in advance for this webinar: https://zoom.us/webinar/register/WN_bldpolKBQcST0VS1cmcEhw After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speakers Wolf H. Fridman (Speaker ) Professor Wolf H. Fridman is Professor Emeritus of Immunology at Université Paris Cité, in Paris, France. His research focused on the analysis of the tumor microenvironment. Since 2005, his studies have changed the paradigm of host/cancer interactions by demonstrating that the ‘immune contexture”, taking in account the functionality, the location and the density of the immune infiltrate is the major prognostic factor for human cancers. He has recently demonstrated that Tertiary Lymphoid Structures (TLS), adjacent to tumor beds shape efficient T and B cell immunity, the later resulting in the production of anti-tumor antibodies that impact patient’s prognosis and response to immunotherapy. These findings open the way for novel immune-based tools for efficient prognosis and therapy of cancers. Rosana Pelayo (Moderator ) Rosana Pelayo holds a Principal Investigator position in the Mexican Institute for Social Security, Puebla, Mexico, where she leads the Oncoimmunology Laboratory. Rosana Pelayo is Past-President of the Mexican Society of Immunology and Vice-Chair of the IUIS Education Committee. Thermo Fisher Scientific (Sponsor ) Thermo Fisher Scientific understands your samples are precious in immunology research. Our products and technologies support your wise use of samples to get qualitative and quantitative measurements when evaluating experiments. Our mission is to enable our customers to make the world healthier, cleaner, and safer.
×
Switch Time Zone
Time Zone:
(GMT-11:00) Midway Island, Samoa
(GMT-11:00) Pago Pago
(GMT-10:00) Hawaii
(GMT-8:00) Alaska
(GMT-8:00) Juneau
(GMT-7:00) Vancouver
(GMT-7:00) Pacific Time (US and Canada)
(GMT-7:00) Tijuana
(GMT-7:00) Arizona
(GMT-7:00) Yukon
(GMT-6:00) Edmonton
(GMT-6:00) Mountain Time (US and Canada)
(GMT-6:00) Mazatlan
(GMT-6:00) Saskatchewan
(GMT-6:00) Guatemala
(GMT-6:00) El Salvador
(GMT-6:00) Managua
(GMT-6:00) Costa Rica
(GMT-6:00) Tegucigalpa
(GMT-6:00) Chihuahua
(GMT-5:00) Winnipeg
(GMT-5:00) Central Time (US and Canada)
(GMT-5:00) Mexico City
(GMT-5:00) Panama
(GMT-5:00) Bogota
(GMT-5:00) Lima
(GMT-5:00) Monterrey
(GMT-5:00) Acre
(GMT-4:00) Montreal
(GMT-4:00) Eastern Time (US and Canada)
(GMT-4:00) Indiana (East)
(GMT-4:00) Puerto Rico
(GMT-4:00) Caracas
(GMT-4:00) Santiago
(GMT-4:00) La Paz
(GMT-4:00) Guyana
(GMT-3:00) Halifax
(GMT-3:00) Montevideo
(GMT-3:00) Recife
(GMT-3:00) Buenos Aires, Georgetown
(GMT-3:00) Sao Paulo
(GMT-3:00) Atlantic Time (Canada)
(GMT-2:30) Newfoundland and Labrador
(GMT-2:00) Greenland
(GMT-2:00) Fernando de Noronha
(GMT-1:00) Cape Verde Islands
(GMT+0:00) Azores
(GMT+0:00) Universal Time UTC
(GMT+0:00) Greenwich Mean Time
(GMT+0:00) Reykjavik
(GMT+0:00) Nouakchott
(GMT+1:00) Dublin
(GMT+1:00) London
(GMT+1:00) Lisbon
(GMT+1:00) Casablanca
(GMT+1:00) West Central Africa
(GMT+1:00) Algiers
(GMT+1:00) Tunis
(GMT+2:00) Belgrade, Bratislava, Ljubljana
(GMT+2:00) Sarajevo, Skopje, Zagreb
(GMT+2:00) Oslo
(GMT+2:00) Copenhagen
(GMT+2:00) Brussels
(GMT+2:00) Amsterdam, Berlin, Rome, Stockholm, Vienna
(GMT+2:00) Amsterdam
(GMT+2:00) Rome
(GMT+2:00) Stockholm
(GMT+2:00) Vienna
(GMT+2:00) Luxembourg
(GMT+2:00) Paris
(GMT+2:00) Zurich
(GMT+2:00) Madrid
(GMT+2:00) Harare, Pretoria
(GMT+2:00) Warsaw
(GMT+2:00) Prague Bratislava
(GMT+2:00) Budapest
(GMT+2:00) Tripoli
(GMT+2:00) Cairo
(GMT+2:00) Johannesburg
(GMT+2:00) Khartoum
(GMT+3:00) Helsinki
(GMT+3:00) Nairobi
(GMT+3:00) Sofia
(GMT+3:00) Istanbul
(GMT+3:00) Athens
(GMT+3:00) Bucharest
(GMT+3:00) Nicosia
(GMT+3:00) Beirut
(GMT+3:00) Damascus
(GMT+3:00) Jerusalem
(GMT+3:00) Amman
(GMT+3:00) Moscow
(GMT+3:00) Baghdad
(GMT+3:00) Kuwait
(GMT+3:00) Riyadh
(GMT+3:00) Bahrain
(GMT+3:00) Qatar
(GMT+3:00) Aden
(GMT+3:00) Djibouti
(GMT+3:00) Mogadishu
(GMT+3:00) Kiev
(GMT+3:00) Minsk
(GMT+3:00) Chisinau
(GMT+4:00) Dubai
(GMT+4:00) Muscat
(GMT+4:00) Baku, Tbilisi, Yerevan
(GMT+4:30) Tehran
(GMT+4:30) Kabul
(GMT+5:00) Yekaterinburg
(GMT+5:00) Islamabad, Karachi, Tashkent
(GMT+5:30) India
(GMT+5:30) Mumbai, Kolkata, New Delhi
(GMT+5:30) Colombo
(GMT+5:45) Kathmandu
(GMT+6:00) Almaty
(GMT+6:00) Dacca
(GMT+6:00) Astana, Dhaka
(GMT+6:30) Rangoon
(GMT+7:00) Novosibirsk
(GMT+7:00) Krasnoyarsk
(GMT+7:00) Bangkok
(GMT+7:00) Vietnam
(GMT+7:00) Jakarta
(GMT+8:00) Irkutsk, Ulaanbaatar
(GMT+8:00) Beijing, Shanghai
(GMT+8:00) Hong Kong SAR
(GMT+8:00) Taipei
(GMT+8:00) Kuala Lumpur
(GMT+8:00) Singapore
(GMT+8:00) Perth
(GMT+9:00) Yakutsk
(GMT+9:00) Seoul
(GMT+9:00) Osaka, Sapporo, Tokyo
(GMT+9:30) Darwin
(GMT+9:30) Adelaide
(GMT+10:00) Vladivostok
(GMT+10:00) Guam, Port Moresby
(GMT+10:00) Brisbane
(GMT+10:00) Canberra, Melbourne, Sydney
(GMT+10:00) Hobart
(GMT+10:30) Lord Howe IsIand
(GMT+11:00) Magadan
(GMT+11:00) Solomon Islands
(GMT+11:00) New Caledonia
(GMT+12:00) Kamchatka
(GMT+12:00) Fiji Islands, Marshall Islands
(GMT+12:00) Auckland, Wellington
(GMT+13:00) Independent State of Samoa
×
Continue to PayPal
Click to Continue
×
×
Upcoming Meetings
Would you like to start this meeting?
Would you like to start one of these meetings?
View more...